Primary pulmonary tumours of neurogenic origin are extremely rare' and since the first case was reported by Rubin (fig 2) , extending medially toward the pulmonary hilum and mediastinum. Bronchoscopy showed uniform congestion of the bronchus intermedius and the middle and lower lobe bronchi and extrinsic upward displacement of the middle lobe bronchus. A soft mass filling the middle lobe and the anterior segments of the lower lobe was found at thoracotomy. Enlarged soft, bluish red hilar and mediastinal nodes were also present. The middle and lower lobes and mediastinal lymph nodes were excised. The mass measured 6 x 11 cm and was greyish, with extensive areas of haemorrhage and necrosis on its cut surface. Adjacent to the middle lobe it was smooth and well encapsulated, whereas close to the lower lobe it was rough, friable, and greyish pink, with cystic and haemorrhagic areas. Histologically the tumour consisted of immature fusiform cells arranged in sheets and cords. Mitotic figures were frequent and cell borders indistinct ( fig  3) . In another area adjacent to the middle lobe the cells tended to form fascicles with a reticulin pattern resembling that of a neurofibroma. The definitive histological diagnosis was malignant schwannoma.
Although the postoperative course was uneventful, some weeks after discharge progressive weakness, weight loss, and caval obstruction occurred. Despite chemotherapy and radiotherapy the patient died four months after surgery. The symptoms of malignant lesions are similar to those of the more common carcinoma of the lung and include anorexia, weight loss, and fever or local symptoms such as thoracic pain, recurrent cough, and haemoptysis. In our fourth patient fever, malaise, anorexia, retrosternal pain, and the high ESR, with radiological evidence of a pulmonary mass, suggested a malignant lesion. In both malignant and benign tumours radiological and clinical features are non-specific and a correct diagnosis is usually made only after surgical exploration. Because of the position of these intrapulmonary tumours, resection of the lung tissue in which it occurs is always indicated.
Grossly benign neoplasms are encapsulated, sometimes lobulated masses of varied dimensions well demarcated from the surrounding tissue. When cut they are yellowish owing to the mucin and lipid content, firm, and solid. Multilocular cystic structures may also be seen. Sometimes the tumour presents as a mass bulging into the bronchial lumen or raising the bronchial mucosa, which may be ulcerated. 4 Malignant neurogenic tumours are usually larger than the benign variety. Although distinct from the surrounding pulmonary parenchyma, they are never encapsulated. Their cut surfaces vary from grey to yellow, with areas of necrosis, haemorrhage, and cystic degeneration. Primary intrapulmonary neurogenic tumours may be divided histologically into neurofibroma and neurilemmoma; neurogenic sarcoma and malignant schwannoma are the malignant equivalents. Histological diagnosis is generally easy in the case of neurilemmoma and neurofibroma, but not always in the case of malignant schwannoma, which should be carefully differentiated from other mesenchymal tumours such as fibrosarcoma and spindle cell anaplastic carcinoma.
The tumour from the fourth patient meets the criteria for a neurogenic tumour as defined by Willis.'0 A benign tumour (neurofibroma) could be macroscopically and microscopically recognised in an area adjacent to the middle lobe, whereas the capsule was absent in other parts of the tumour, strongly suggesting a malignant schwannoma.
The association between primary neurogenic pulmonary tumours and von Recklinghausen's disease is well known. This syndrome, which is basically due to a defect in the development of Schwann cells, is characterised by the presence of multiple neurofibromas in the skin and internal organs. Ackerman and Taylor" maintain that in such cases the proportion of malignant neurofibromas is very high, whereas others maintain that malignant mediastinal tumours are most likely to be malignant schwannomas. ' 2 Schwannomas were reported by Stout'3 to account for 18%. There was no evidence of von Recklinghausen's disease in our patients.
In patients without von Recklinghausen's disease the prognosis of benign neurogenic tumours is good and there were no recurrences in the published cases. Our three patients are still alive and well four to 12 years after surgery. Malignant schwannoma, on the other hand, tends to recur and the survival rate is low. Although Neilson reported a malignant schwannoma in a 35 year old man who is still alive two years after surgery, death generally supervenes within a few weeks'4 and our patient died four months after operation from metastatic spread.
